University of Zurich, Institute of Social and Preventive Medicine, Medical Economics, Zurich, Switzerland.
University of Zurich, Institute of Social and Preventive Medicine, Medical Economics, Zurich, Switzerland.
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):926-32. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.042. Epub 2013 Oct 8.
Few useful empirical data on stroke are available for Switzerland. The aim of this study was to collect data on the use of medical resources and associated costs among stroke patients. Special attention was paid to possible correlations between epidemiologic indicators, sociodemographic variables, resource use, and costs.
We carried out a representative population survey of 19,123 households in the German- and French-speaking parts of Switzerland with computer-assisted telephone interviews in 2005. Detailed sociodemographic data and information on the use of resources were collected from 509 individuals aged 15-75 years who had cared for a stroke patient in the past 1-2 years.
In the last 1-2 years, a total of 7.8% of households were affected by stroke in the German-speaking part of Switzerland, whereas only 4.3% of households were affected in the French-speaking part of Switzerland (odds ratio [OR] = 1.89, P < .001). Based on the length of stay, the total cost of inpatient treatment and rehabilitation during the average 1-year observation period was estimated at €40,090. Stroke therefore caused approximately 2.9% of all inpatient costs in Switzerland. Patients with supplementary insurance were treated more frequently as inpatients than patients with statutory insurance (OR: 2.14, P = .014), and patients with a low household income were referred less frequently to an inpatient rehabilitation facility than those with medium or high household income (OR = .58, P < .05).
This survey confirms the medical and economic importance of stroke and supplements the existing European data. Further research is needed in regard to incidence differences in stroke across Switzerland. Patients without supplementary insurance or with low household income were less likely to receive inpatient treatment.
瑞士缺乏有关中风的有用经验数据。本研究的目的是收集中风患者使用医疗资源和相关费用的数据。特别关注流行病学指标、社会人口统计学变量、资源利用和成本之间可能存在的相关性。
我们在瑞士德语区和法语区的 19123 户家庭中进行了一项具有代表性的人群调查,2005 年通过计算机辅助电话访谈进行。从过去 1-2 年内照顾过中风患者的 509 名 15-75 岁的个体中收集了详细的社会人口统计学数据和资源使用信息。
在过去的 1-2 年中,瑞士德语区共有 7.8%的家庭受到中风的影响,而法语区只有 4.3%的家庭受到影响(比值比 [OR] = 1.89,P<.001)。根据住院时间,在平均 1 年的观察期内,住院治疗和康复的总费用估计为 40090 欧元。因此,中风导致瑞士所有住院费用的约 2.9%。有补充保险的患者比有法定保险的患者更频繁地接受住院治疗(OR:2.14,P =.014),而家庭收入较低的患者比家庭收入中等或较高的患者更不容易被转介到住院康复机构(OR =.58,P <.05)。
本调查证实了中风的医疗和经济重要性,并补充了现有的欧洲数据。需要进一步研究瑞士各地中风发病率的差异。没有补充保险或家庭收入较低的患者接受住院治疗的可能性较低。